Skip to main content

Michael Sefton to receive Lifetime Achievement Award from the Tissue Engineering & Regenerative Medicine International Society

Image
By
University of Toronto biomedical engineering University Professor Michael Sefton (IBBME, ChemE) has been named this year’s recipient of the Lifetime Achievement Award from the Tissue Engineering & Regenerative Medicine International Society (TERMIS). The award, issued by the organization’s Americas chapter, recognizes his immense contributions to the fields of tissue engineering and regenerative medicine.

Sefton joins an elite list of renowned recipients, including MIT professor of chemical engineering Robert Langer and founding director of the University of Pittsburgh’s McGowan Institute for Regenerative Medicine, Alan Russell.

Sefton has made significant contributions to research advances in biomaterials, biomedical engineering and regenerative medicine. He was one of the first to combine living cells with polymers, effectively launching the field now now called tissue engineering. Recently, his lab has created biomaterials that actively promote the growth of blood vessels — such materials accelerate wound healing and support the development of lab-grown tissues.



Among his numerous awards and accolades, Sefton received the European Society for Biomaterials International Award in April, the Terumo Global Science Prize in January and was named last year to the U.S. National Institute of Medicine. He holds the title of University Professor, the highest academic rank at the University of Toronto, reserved for less than two per cent of tenured faculty.

A leader in his professional community, he served as president of the U.S. Society for Biomaterials in 2005 and has spearheaded several programs to advance the field. From 1999 to 2005, Sefton was director of the Institute of Biomaterials & Biomedical Engineering (IBBME) leading its development into one of the top institutes of its kind in North America.

“This is a terrific recognition of Michael’s outstanding efforts throughout his career in advancing the field of tissue engineering,” said IBBME director Professor Christopher Yip.

Sefton will be presented with the award at the 2016 TERMIS-AM conference to take place from December 11 to 14 in San Diego, California.

Source: http://goo.gl/UtBV0Y

Comments

Post a Comment

Popular posts from this blog

Reforming Hair Loss Treatment With Stem Cells

By
Losing hair can be very frustrating and insulting, and for years, people have been looking for different methods to treat hair loss effectively. Presently, people mainly rely on hair transplant to treat hair loss problem. However, things are going to change for the better in the near future, with the advent of stem cell therapy for Hair Loss Treatment . Research and tests suggest that this can be a very viable treatment to cure hair loss. The procedure is non-surgical and it helps in stimulating and re-growing the hair follicles. The existing methods vs. the new method of hair loss treatment On one hand where the existing methods of Hair Loss Treatment depends on transplantation of hair follicles from one section to another section of your head, the stem cell therapy, on the other hand, provides an infinite source of stem cells taken from the patient. There is no limitation as far as availability of hair follicles is concerned. This kind of treatment will be the most benefi...
1 comment
Read more

Know About ​Mesenchymal stem cells (MSCs)

By
 Know About ​Mesenchymal stem cells (MSCs) ​Mesenchymal stem cells (MSCs) are a type of adult stem cell found in several tissues in the body, including bone marrow, adipose tissue, and umbilical cord tissue. They have the ability to differentiate into multiple cell types, such as osteoblasts, chondrocytes, and adipocytes, which are responsible for bone, cartilage, and fat tissue formation, respectively. MSCs have gained significant attention in recent years due to their potential use in regenerative medicine. They have the ability to secrete various growth factors and cytokines that promote tissue repair and regeneration. Additionally, they have immunomodulatory properties that make them attractive candidates for treating autoimmune diseases and reducing inflammation. MSCs have been used in various preclinical and clinical trials to treat a wide range of conditions, including osteoarthritis, cardiovascular disease, and neurological disorders, among others. They can be isolated from...
Post a Comment
Read more

Stem Cell Therapy for Liver Cirrhosis

By
 Stem Cell Therapy for Liver Cirrhosis Stem cell therapy is a promising area of research for the treatment of liver cirrhosis. Liver cirrhosis is a progressive condition in which the liver becomes scarred and damaged, leading to a loss of liver function. This can be caused by a variety of factors, including chronic alcohol abuse, viral hepatitis, and non-alcoholic fatty liver disease. Stem cells have the potential to regenerate damaged tissues and organs, including the liver. In the case of liver cirrhosis, stem cells can differentiate into liver cells and promote the growth of healthy tissue, thereby restoring liver function. Web: https://www.giostar.com/Therapy/liver-diseases/ Email: stemcells@giostar.com GIOSTAR Ahmedabad:  +91-7043008890 GIOSTAR Bangalore: +91-6366209990 GIOSTAR Chandigarh: +91-9501768105 #STEM #stemcells #therapy #liver #cirrhosis #giostar #livercirrhosis #liverdisease #giostarindia
Post a Comment
Read more